Shapiro R, Randhawa P, Jordan M L, Scantlebury V P, Vivas C, Jain A, Corry R J, McCauley J, Johnston J, Donaldson J, Gray E A, Dvorchik I, Hakala T R, Fung J J, Starzl T E
University of Pittsburgh, Thomas E. Starzl Transplantation Institute, PA 15213, USA.
Am J Transplant. 2001 May;1(1):47-50. doi: 10.1034/j.1600-6143.2001.010109.x.
To investigate the possibility that we have been underestimating the true incidence of acute rejection, we began to perform protocol biopsies after kidney transplantation. This analysis looks at the one-week biopsies. Between March 1 and October 1, 1999, 100 adult patients undergoing cadaveric kidney or kidney/pancreas transplantation, or living donor kidney transplantation, underwent 277 biopsies. We focused on the subset of biopsies in patients without delayed graft function (DGF) and with stable or improving renal function, who underwent a biopsy 8.2+/-2.6 d (range 3-18 d) after transplantation (n = 28). Six (21%) patients with no DGF and with stable or improving renal function had borderline histopathology, and 7 (25%) had acute tubulitis on the one-week biopsy. Of the 277 kidney biopsies, there was one (0.4%) serious hemorrhagic complication, in a patient receiving low molecular weight heparin; she ultimately recovered and has normal renal function. Her biopsy showed Banff 1B tubulitis. In patients with stable or improving renal allograft function early after transplantation, subclinical tubulitis may be present in a substantial number of patients. This suggests that the true incidence of rejection may be higher than is clinically appreciated.
为了研究我们是否一直在低估急性排斥反应的真实发生率,我们开始在肾移植后进行常规活检。本分析关注的是术后一周的活检情况。在1999年3月1日至10月1日期间,100例接受尸体肾或肾/胰移植、或活体供肾移植的成年患者接受了277次活检。我们重点关注了那些没有移植肾功能延迟恢复(DGF)且肾功能稳定或改善的患者的活检子集,这些患者在移植后8.2±2.6天(范围3 - 18天)接受了活检(n = 28)。6例(21%)没有DGF且肾功能稳定或改善的患者组织病理学表现为临界状态,7例(25%)在术后一周的活检中出现急性肾小管炎。在277次肾活检中,有1例(0.4%)出现严重出血并发症,该患者正在接受低分子量肝素治疗;她最终康复且肾功能正常。她的活检显示为班夫1B级肾小管炎。在移植后早期肾功能稳定或改善的患者中,相当一部分患者可能存在亚临床肾小管炎。这表明排斥反应的真实发生率可能高于临床认识到的水平。